Budigalimab (Anti-PDCD1 / PD-1 / CD279)Budigalimab (Anti-PDCD1 / PD-1 / CD279)
Move your mouse over image or click to enlarge

Budigalimab (Anti-PDCD1 / PD-1 / CD279)

Budigalimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.84 KD.
Cat# Size Price Qty Buy
A3028-1mg*25 1mg*25
£2,432.00
A3028-1mg*5 1mg*5
£794.00
A3028-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3028

Related Documents